101 related articles for article (PubMed ID: 25769078)
41. Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes.
Itoh T; Iwahashi S; Kanak MA; Shimoda M; Takita M; Chujo D; Tamura Y; Rahman AM; Chung WY; Onaca N; Coates PT; Dennison AR; Naziruddin B; Levy MF; Matsumoto S
Cell Transplant; 2014 Feb; 23(2):153-65. PubMed ID: 23211332
[TBL] [Abstract][Full Text] [Related]
42. Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D.
Roels S; Costa OR; Tersey SA; Stangé G; De Smet D; Balti EV; Gillard P; Keymeulen B; Ling Z; Pipeleers DG; Gorus FK; Mirmira RG; Martens GA
J Clin Endocrinol Metab; 2019 Feb; 104(2):451-460. PubMed ID: 30203041
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Toll-like Receptor 4 Using Small Molecule, TAK-242, Protects Islets from Innate Immune Responses.
Mattke J; Darden CM; Vasu S; Lawrence MC; Kirkland J; Kane RR; Naziruddin B
Cells; 2024 Feb; 13(5):. PubMed ID: 38474380
[TBL] [Abstract][Full Text] [Related]
44. Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation.
Beuneu C; Vosters O; Movahedi B; Remmelink M; Salmon I; Pipeleers D; Pradier O; Goldman M; Verhasselt V
Diabetes; 2004 Jun; 53(6):1407-11. PubMed ID: 15161741
[TBL] [Abstract][Full Text] [Related]
45. Use of anti-inflammatory agents in clinical islet cell transplants: A qualitative systematic analysis.
Szempruch KR; Banerjee O; McCall RC; Desai CS
Islets; 2019; 11(3):65-75. PubMed ID: 31149871
[TBL] [Abstract][Full Text] [Related]
46. Thrombomodulin expression on Langerhans' islet: can endogenous 'anticoagulant on demand' overcome detrimental thrombotic complications in clinical islet transplantation?
Iino S; Abeyama K; Kawahara KI; Aikou T; Maruyama I
J Thromb Haemost; 2004 May; 2(5):833-4. PubMed ID: 15099291
[No Abstract] [Full Text] [Related]
47. Serum miR-21 levels in patients with dermatomyositis.
Shimada S; Jinnin M; Ogata A; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Inoue K; Fukushima S; Ihn H
Clin Exp Rheumatol; 2013; 31(1):161-2. PubMed ID: 23137528
[No Abstract] [Full Text] [Related]
48. Enumerating β-Cells in Whole Human Islets: Sex Differences and Associations With Clinical Outcomes After Islet Transplantation.
Marchese E; Rodeghier C; Monson RS; McCracken B; Shi T; Schrock W; Martellotto J; Oberholzer J; Danielson KK
Diabetes Care; 2015 Nov; 38(11):e176-7. PubMed ID: 26384388
[No Abstract] [Full Text] [Related]
49. Erratum to "Prenatal caffeine exposure caused H-type blood vessel-related long bone dysplasia via miR375/CTGF signaling".
FASEB J; 2023 Feb; 37(2):e22775. PubMed ID: 36645105
[No Abstract] [Full Text] [Related]
50. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
51. Juvenile porcine islets can restore euglycemia in diabetic athymic nude mice after xenotransplantation.
Krishnan R; Buder B; Alexander M; Foster CE; Lakey JR
Transplantation; 2015 Apr; 99(4):710-6. PubMed ID: 25793438
[TBL] [Abstract][Full Text] [Related]
52. Controlled aggregation of primary human pancreatic islet cells leads to glucose-responsive pseudoislets comparable to native islets.
Hilderink J; Spijker S; Carlotti F; Lange L; Engelse M; van Blitterswijk C; de Koning E; Karperien M; van Apeldoorn A
J Cell Mol Med; 2015 Aug; 19(8):1836-46. PubMed ID: 25782016
[TBL] [Abstract][Full Text] [Related]
53. Characterization of Innate Immunity in an Extended Whole Blood Model of Human Islet Allotransplantation.
Hårdstedt M; Lindblom S; Karlsson-Parra A; Nilsson B; Korsgren O
Cell Transplant; 2016; 25(3):503-15. PubMed ID: 26084381
[TBL] [Abstract][Full Text] [Related]
54. Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes?
Robertson RP
Diabetes Care; 2015 Jun; 38(6):1030-5. PubMed ID: 25998295
[TBL] [Abstract][Full Text] [Related]
55. iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.
Cheng PP; Liu XC; Ma PF; Gao C; Li JL; Lin YY; Shao W; Han S; Zhao B; Wang LM; Fu JZ; Meng LX; Li Q; Lian QZ; Xia JJ; Qi ZQ
Stem Cells Dev; 2015 Aug; 24(15):1793-804. PubMed ID: 25867817
[TBL] [Abstract][Full Text] [Related]
56. Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes.
Hajizadeh-Saffar E; Tahamtani Y; Aghdami N; Azadmanesh K; Habibi-Anbouhi M; Heremans Y; De Leu N; Heimberg H; Ravassard P; Shokrgozar MA; Baharvand H
Sci Rep; 2015 Mar; 5():9322. PubMed ID: 25818803
[TBL] [Abstract][Full Text] [Related]
57. Factors associated with islet yield and insulin independence after total pancreatectomy and islet cell autotransplantation in patients with chronic pancreatitis utilizing off-site islet isolation: Cleveland Clinic experience.
Johnston PC; Lin YK; Walsh RM; Bottino R; Stevens TK; Trucco M; Bena J; Faiman C; Hatipoglu BA
J Clin Endocrinol Metab; 2015 May; 100(5):1765-70. PubMed ID: 25781357
[TBL] [Abstract][Full Text] [Related]
58. Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants.
Monti P; Vignali D; Piemonti L
Curr Diabetes Rev; 2015; 11(3):135-43. PubMed ID: 25777058
[TBL] [Abstract][Full Text] [Related]
59. Early Metabolic Measures Predict Long-term Insulin Independence in Recipients of Total Pancreatectomy and Islet Autotransplantation.
Nanno Y; Hodges JS; Freeman ML; Trikudanathan G; Schwarzenberg SJ; Downs EM; Ramanathan K; Pruett TL; Beilman GJ; Chinnakotla S; Hering BJ; Bellin MD
Transplant Direct; 2024 Jan; 10(1):e1561. PubMed ID: 38094130
[TBL] [Abstract][Full Text] [Related]
60. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge.
Caldara R; Tomajer V; Monti P; Sordi V; Citro A; Chimienti R; Gremizzi C; Catarinella D; Tentori S; Paloschi V; Melzi R; Mercalli A; Nano R; Magistretti P; Partelli S; Piemonti L
Front Immunol; 2023; 14():1323439. PubMed ID: 38077372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
